TAP installs CompacT SelecT culture system at US biodefence campus to produce high quality cell lines

NewsGuard 100/100 Score

The Automation Partnership (TAP), a world leader in the design and development of innovative automation for life science applications, today announced CompacT SelecT™ automated cell culture system is being installed at a prestigious, new US defence facility, to produce high quality cell lines in containment conditions.

The CompacT SelecT system sited at this US biodefence campus, part of a foremost medical research centre, will be used for unattended culturing of high quality, assay-ready mammalian cell lines. The system will allow researchers at the facility to safely maintain cells in flasks, as well as standard and transport assay plates, by making programmed media changes in the flasks and plates, all without any manual intervention

Compact SelecT will enable the culture of many cell lines in parallel without risking cross contamination. The system uses sophisticated tracking to record all processing steps and means researchers can verify the contents of each sample, which is crucial in this facility.

Tim Ward, Director of Cell Culture at TAP explained: "The biodefence facility wanted an automated cell culture system that closely mimicked the centre's manual handling processes, so that their scientists would not need to make fundamental workflow changes to accommodate the automation into their research. As an established technology proven to successfully culture a vast number of different cell types, they felt confident in choosing CompacT SelecT to help them transition from manual to automated cell culture, while ensuring the quality of cell lines and their personal safety."

Source:

The Automation Partnership

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Discovery of new vascular cell type may pave way for novel strategies to treat cardiovascular diseases